Si Qin, Su Longga, Wang Dong, De Bao-Jun, Na Risu, He Nagongbilige, Byambaa Tserentsoo, Dalkh Tserendagva, Bao Xilinqiqige, Yi Letai
Scientific Research Department, Inner Mongolia International Mongolian Hospital, Hohhot, 010065, China; Inner Mongolia Azitai Mongolian Medicine Psychosomatic Research Co., Ltd., Ordos, 017004, China.
Medicine Innovation Center for Nationalities, Inner Mongolia Medical University, Hohhot, 010110, China; Drug Quality Testing Center, Ordos Mongolian Hospital, Ordos, 017010, China.
J Ethnopharmacol. 2023 Jun 28;310:116331. doi: 10.1016/j.jep.2023.116331. Epub 2023 Mar 16.
The contents and types of the active compounds in medicinal herbs depend greatly on their extraction methods, sources of origin and the modes of cultivation. Platycodon grandiflorus (Jacq.) A.DC. is an ethnic medicinal herb widely cultivated in China, and its dried root, Platycodi Radix (PR), is an important ingredient in herbal formulae for attenuating lung issues in Mongolian medical practice. However, research evaluating the superiority of PR based on harvesting regions is relatively limited.
This study aimed to evaluate the qualitative superiority of PR from different regions based on anti-inflammatory effect.
A total of three commercial PR samples were obtained from Anguo, Bozhou and Shangluo, and two wild samples were obtained from Chifeng and Hinggan. PR extract (PRE) was prepared by water distillation, and platycodin D content in the extract was examined by HPLC-UVD. An optimal dose of PRE was administered to BALB/c mice with S. pneumoniae pneumonia, and IL-10 and TNF-α levels in lung tissue were examined by ELISA. HepG2 cells were treated with PRE, and an analysis of differentially expressed gene and functional enrichment was performed using an HTS assay.
The contents of moisture, total ash, crude extract and platycodin D in the raw roots met the quality control requirements outlined in the Chinese Pharmacopoeia (2020 edition). The platycodin D content in the aqueous extract of the roots in descending order was 24.16% in PRE_Shangluo, 22.91% in PRE_Hinggan, 21.41% in PRE_Bozhou, 17.8% in PRE_Chifeng and 15.92% in PRE_Anguo. Furthermore, administration of PREs at an optimal dose of 2.0 g/kg resulted in some anti-inflammatory effect in mice with Streptococcus pneumoniae pneumonia, among which PRE_Shangluo administration exhibited a more obvious anti-inflammatory impact as shown by a significant decrease in the plasma white cell count (p < 0.05) and IL-10 level elevation and TNF-α reduction in lung tissue (p < 0.05) after treatment. In HepG2 cells treated with 100 μg/ml of each PRE, PRE_Hinggan and PRE_Shangluo resulted in significant differential expression of genes such as nuclear factor kappa B subunit 1 (NFKB1) and significant enrichment of pathways involved in the immune system, such as PI3K-Akt, MAPK and NF-kappa B signaling pathways.
In this study, based on the anti-inflammatory effect, the quality of PR of Shangluo origin was superior to that of PR from the other four regions.
草药中活性成分的含量和种类在很大程度上取决于其提取方法、产地来源和种植方式。桔梗(Platycodon grandiflorus (Jacq.) A.DC.)是一种在中国广泛种植的民族草药,其干燥根,即桔梗(Platycodi Radix,PR),是蒙医中用于缓解肺部问题的草药配方中的重要成分。然而,基于采收地区评估桔梗质量优势的研究相对有限。
本研究旨在基于抗炎作用评估不同地区桔梗的质量优势。
从安国、亳州和商洛共获得3个市售桔梗样品,从赤峰和兴安获得2个野生样品。通过水蒸馏法制备桔梗提取物(PRE),采用高效液相色谱 - 紫外检测器(HPLC - UVD)检测提取物中桔梗皂苷D的含量。将最佳剂量的PRE给予患有肺炎链球菌肺炎的BALB/c小鼠,采用酶联免疫吸附测定(ELISA)检测肺组织中白细胞介素 - 10(IL - 10)和肿瘤坏死因子 - α(TNF - α)水平。用PRE处理人肝癌细胞系HepG2细胞,采用高通量测序(HTS)分析进行差异表达基因分析和功能富集分析。
生药中水分、总灰分、粗提取物和桔梗皂苷D的含量符合《中国药典》(2020年版)规定的质量控制要求。根水提取物中桔梗皂苷D含量由高到低依次为:PRE_商洛24.16%、PRE_兴安22.91%、PRE_亳州21.41%、PRE_赤峰17.8%、PRE_安国15.92%。此外,以2.0 g/kg的最佳剂量给予PREs对肺炎链球菌肺炎小鼠有一定抗炎作用,其中给予PRE_商洛后抗炎作用更明显,表现为治疗后血浆白细胞计数显著降低(p < 0.05),肺组织中IL - 10水平升高、TNF - α降低(p < 0.05)。在用100 μg/ml的各PRE处理的HepG2细胞中,PRE_兴安和PRE_商洛导致核因子κB亚基1(NFKB1)等基因显著差异表达,以及PI3K - Akt、MAPK和NF - κB信号通路等免疫系统相关通路显著富集。
本研究基于抗炎作用表明,商洛产桔梗的质量优于其他四个地区的桔梗。